Through research, education and clinical work, I hope to help patients with osteoporosis and fracture risk. In those affected, there is compromise to their quality of life which is preventable through application of available technology and likely to be better addressed by advances which our research studies contribute to.
metabolic bone disease, evaluation of fracture risk, antiresprptive therapy, bone anabolic therapy
Our focus is on research into the technologies of assessment of skeletal health and the therapies which can be employed to improve bone strength. Allied with this is our research into muscle strength and falls prevention in the elderly.
- 1989 EA Baker fellowship
- 1991 McLaughlin fellowship
- 2010 International Society for Clinical Densitometry Global Leadership Award